**Core Concept:** Vitamin A is an essential micronutrient required for various physiological processes, particularly visual development and immune system function. It is found in animal-based sources such as liver, fish oils, and dairy products, as well as plant-based sources like carotenoids like beta-carotene found in fruits and vegetables. Vitamin A deficiency (VAD) can lead to xerophthalmia, a group of ocular disorders, and impaired immune response, increasing susceptibility to infections. Prophylactic doses of vitamin A are given to prevent VAD-related complications in high-risk children.

**Why the Correct Answer is Right:**
Children aged 6-59 months who are malnourished, have a history of measles, or reside in areas with poor sanitation are considered high-risk groups for vitamin A deficiency. For these children, the World Health Organization (WHO) recommends prophylactic doses of vitamin A to reduce morbidity and mortality related to VAD. The recommended dose for children aged 6-59 months is 200,000 IU (International Units) of retinyl palmitate, which is a form of vitamin A. Retinyl palmitate is chosen over other forms because of its long half-life and high bioavailability.

**Why Each Wrong Option is Incorrect:**

A. 200,000 IU Retinyl palmitate is the correct dose for prophylaxis, but the administration route is oral, not intramuscular (IM) as stated in option A.
B. The dose is correct (200,000 IU of retinyl palmitate), but the administration route is incorrect (oral, not intramuscular).
C. The administration route is correct (intramuscular), but the dose (100,000 IU) is half of the recommended prophylactic dose for children aged 6-59 months.
D. The administration route is correct (intramuscular), but the dose (100,000 IU) is half of the recommended prophylactic dose for children aged 6-59 months.

**Clinical Pearl:** The World Health Organization (WHO) guidelines recommend administering prophylactic vitamin A to children aged 6-59 months as follows:

1. Intramuscular (IM) injection is preferred due to better bioavailability and reduced side effects like gastrointestinal upset.
2. The recommended dose is 200,000 IU of retinyl palmitate to prevent vitamin A deficiency-related morbidity and mortality in high-risk children.

By following the WHO's guidelines, the correct administration route is intramuscular injection, and the correct dose is 200,000 IU of retinyl palmitate to ensure effective prevention of vitamin A deficiency-related illnesses in high-risk pediatric patients.